The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode

Authors
Category Primary study
JournalNeuropsychiatric Disease and Treatment
Year 2014
This article has no abstract
Epistemonikos ID: bfe8a820943114767e992d566463471d0de9b4c6
First added on: Feb 06, 2025